Latest On ALK-Abelló A/S (AKBLF):
About ALK-Abelló A/S (AKBLF):
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. Its products include GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
General
- Name ALK-Abelló A/S
- Symbol AKBLF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 2,447
- Fiscal Year EndDecember
- Web URLhttp://www.alk.net
Valuation
- Price/Sales (Trailing 12 Mt.) 7.64
- Price/Book (Most Recent Quarter) 8.41
- Enterprise Value Revenue 1.25
- Enterprise Value EBITDA 11.51
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.61
- Next Year EPS Estimate $6.13
- Profit Margin 1%
- Return on Assets 2%
- Return on Equity 1%
- Revenue Per Share $0
- Gross Profit 2.05 billion
- Quarterly Earnings Growth 12.2%
Highlights
- Market Capitalization 4.15 billion
- PEG Ratio 779.93
Share Statistics
- Shares Outstanding 9.89 million
- Shares Float 6.43 million
- % Held by Insiders <1%
- % Held by Institutions 61.43%
Technicals
- Beta 0.19
- 52 Week High $418
- 52 Week Low $259.5
- 50 Day Moving Average 373.2
- 200 Day Moving Average 287.52
Dividends
- Dividend Date N/A
- ExDividend Date 2017-03-16
- Dividend Yield 0%
ALK-Abelló A/S (AKBLF) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
ALK-Abelló A/S (AKBLF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $N/A | -$0.45 | $0.58 | -177.59% |
2020-09-30 | 2020-12-31 | $N/A | -$0.47 | -$3.30 | 85.62% |
2020-06-30 | 2020-09-30 | $N/A | -$0.28 | -$2.30 | 87.68% |
2020-03-31 | 2020-06-30 | $956 million | -$0.14 | $3.30 | -104.11% |
2019-12-31 | 2020-03-31 | $132.52 million | $1.15 | -$3.40 | 133.9% |
2019-09-30 | 2019-12-31 | $107.89 million | -$0.18 | -$2.61 | 93.15% |
2019-06-30 | 2019-09-30 | $118.69 million | -$0.19 | -$2.28 | 91.76% |
2019-03-31 | 2019-06-30 | $130.23 million | -$0.94 | $2.40 | -139.36% |
2018-12-31 | 2019-03-31 | $120.87 million | $0.62 | -$2.12 | 129.06% |
2018-09-30 | 2018-12-31 | $102.64 million | -$20.13 | -$6.85 | -193.83% |
2018-06-30 | 2018-09-30 | $111.68 million | -$0.37 | -$8.02 | 95.34% |
2018-03-31 | 2018-06-30 | $124.19 million | -$0.25 | -$7.36 | 96.59% |
2017-12-31 | 2018-03-31 | $123.03 million | $0.36 | -$2.02 | 117.62% |
2017-09-30 | 2017-12-31 | $105.14 million | -$2.36 | -$1.47 | -60.63% |
2017-06-30 | 2017-08-16 | $691 million | -$0.02 | $1.90 | -100.79% |
2017-03-31 | 2017-06-30 | -$0.02 | |||
2016-12-31 | 2017-03-31 | $0.03 | $3.30 | -99.12% | |
2016-09-30 | 2016-12-31 | $0.51 | $2.80 | -81.83% | |
2016-06-30 | 2016-09-30 | $0.60 | $4.70 | -87.16% | |
2016-03-31 | 2016-06-30 | $1.04 | $9.55 | -89.06% | |
2015-12-31 | 2016-03-31 | $1.83 | |||
2015-09-30 | 2015-12-31 | $2.01 | -$0.73 | 374.73% | |
2015-06-30 | 2015-09-30 | $0.90 | -$0.80 | 212.18% | |
2015-03-31 | 2015-06-30 | $0.75 | |||
2014-12-31 | 2015-03-31 | $1.30 | $5.74 | -77.35% | |
2014-09-30 | 2014-12-31 | $0.26 | -$0.96 | 127.48% | |
2014-06-30 | 2014-09-30 | $0.45 | $1.09 | -59.09% | |
2014-03-31 | 2014-06-30 | $0.57 | $6.63 | -91.33% | |
2013-12-31 | 2014-03-31 | $2.01 | $3.21 | -37.34% | |
2013-09-30 | 2013-12-31 | $0.75 | $0.00 | ||
2013-06-30 | 2013-09-30 | $0.17 | $0.00 | ||
2013-03-31 | 2013-06-30 | -$0.54 | $0.00 | ||
2012-12-31 | 2013-03-31 | $0.74 | $0.00 | ||
2012-09-30 | 2012-12-31 | -$0.27 | $0.00 | ||
2012-06-30 | 2012-09-30 | $0.99 | $0.00 | ||
2012-03-31 | 2012-06-30 | -$0.47 | $0.00 | ||
2011-12-31 | 2012-03-31 | $0.73 | $0.00 | ||
2011-09-30 | 2011-12-31 | $0.34 | $0.00 | ||
2011-06-30 | 2011-09-30 | $0.75 | $0.00 | ||
2011-03-31 | 2011-06-30 | $0.26 | $0.00 | ||
2010-12-31 | 2011-03-31 | $2.44 | $0.00 | ||
2010-09-30 | 2010-12-31 | $0.72 | $0.00 |
ALK-Abelló A/S (AKBLF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | 113 million | 22.36 million |
Income Before Tax | N/A | N/A | N/A | 122 million | -2.1 million |
Selling General Administrative | N/A | N/A | N/A | 335 million | 58.53 million |
Gross Profit | N/A | N/A | N/A | 585 million | 77.29 million |
Ebit | N/A | N/A | N/A | 198 million | -4.5 million |
Operating Income | N/A | N/A | N/A | 137 million | -4.5 million |
Income Tax Expense | 17 million | 7 million | 16 million | 36 million | 2.25 million |
Total Revenue | N/A | N/A | N/A | 956 million | 132.52 million |
Cost of Revenue | N/A | N/A | N/A | 371 million | 55.23 million |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | 2.4 million |
Net Income From Continuing Operations | N/A | N/A | N/A | 86 million | -4.35 million |
Net Income Applicable to Common Shares | -31 million | -20 million | -10 million | 86 million | -4.35 million |
Cash Flow:
Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
---|---|---|---|---|---|
Investments | N/A | N/A | -49 million | 150082.55 | 145989.66 |
Change to Liabilities | N/A | N/A | N/A | 23.86 million | N/A |
Total Cash Flow from Investing Activities | -46 million | -78 million | -49 million | -4.95 million | -6.13 million |
Net Borrowings | -16 million | -11 million | -10 million | -2.55 million | -1.02 million |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | -1.35 million | -1.02 million |
Change to Operating Activities | -90 million | 56 million | -135 million | 28.52 million | -1.9 million |
Change in Cash | N/A | N/A | 7 million | 22.36 million | -5.84 million |
Total Cash from Operating Activities | -48 million | 84 million | 70 million | 28.82 million | 1.02 million |
Depreciation | N/A | N/A | 61 million | 3.75 million | 7.88 million |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | N/A | N/A | N/A | -8.1 million | -7.88 million |
Change to Account Receivables | N/A | N/A | N/A | -30.02 million | -29.2 million |
Other Cash Flow from Financing Activities | N/A | -20 million | -4 million | N/A | N/A |
Change to Net Income | 182 million | -21 million | 58 million | 10.21 million | -2.92 million |
Capital Expenditures | N/A | N/A | 49 million | 8.1 million | 5.26 million |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Total Liabailities | N/A | N/A | N/A | 2.36 billion | 348.04 million |
Total Stockholder Equity | N/A | N/A | N/A | 3.28 billion | 476.66 million |
Other Current Liabilities | 905 million | 818 million | N/A | N/A | 120.67 million |
Total Assets | N/A | N/A | N/A | 5.64 billion | 824.7 million |
Common Stock | 111 million | 111 million | 111 million | 111 million | 16.66 million |
Other Current Assets | N/A | N/A | N/A | N/A | N/A |
Retained Earnings | 3.17 billion | 3.16 billion | 3.16 billion | 3.17 billion | 462.85 million |
Other Liabilities | 488 million | 485 million | 476 million | 458 million | 66.64 million |
Other Assets | 895 million | 851 million | 863 million | 817 million | 117.06 million |
Cash | N/A | N/A | N/A | 322 million | 47.43 million |
Total Current Liabilities | 1.03 billion | 976 million | N/A | 968 million | 140.18 million |
Other Stockholder Equity | -125 million | -72 million | -27 million | N/A | -2.85 million |
Property, Plant & Equipment | 1.7 billion | 1.72 billion | 1.74 billion | 1.76 billion | 260.99 million |
Total Current Assets | 2.34 billion | 2.3 billion | N/A | 2.35 billion | 337.39 million |
Long Term Investments | N/A | N/A | N/A | N/A | 6.9 million |
Net Tangible Assets | 2.53 billion | 2.55 billion | 2.58 billion | 2.6 billion | 374.31 million |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | N/A | N/A | N/A | 703 million | 106.11 million |
Inventory | 1.09 billion | 1.13 billion | N/A | 1.06 billion | 158.49 million |
Accounts Payable | 74 million | 109 million | N/A | 106 million | 12.16 million |
ALK-Abelló A/S (AKBLF) Chart:
ALK-Abelló A/S (AKBLF) News:
Below you will find a list of latest news for ALK-Abelló A/S (AKBLF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ALK-Abelló A/S (AKBLF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
ALK-Abelló A/S (AKBLF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|